Biotech Showcase is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Alex Zisson
Managing Director at H.I.G. Capital


Alex focuses on investments in the biopharmaceuticals industry, especially in pharmaceuticals, generics, drug delivery and specialty pharma and biotechnology. He joined H.I.G. Capital as a Managing Director in January 2016. He currently serves on the board of directors for Clarus Therapeutics, Leiter’s, and Neurana Pharma. Prior to H.I.G., Alex was spent 13 years making similar investments at Thomas, McNerney & Partners. Prior to Thomas, McNerney, Alex spent 11 years in the research department at Hambrecht & Quist. During his tenure at H&Q, Alex led research teams covering the biotechnology, specialty pharmaceuticals, large-cap pharmaceuticals, drug delivery and diagnostics industries. After the merger of Chase H&Q and JPMorgan, Alex became the firm’s healthcare strategist. He graduated magna cum laude from Brown University, where he was elected to Phi Beta Kappa.

Agenda Sessions

  • An H&Q reunion: A retrospective look at the biotech sector with former analysts - Hilton Union Square


Speakers at this event